Log in to save to my catalogue

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-epi...

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-epi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3594563

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis

About this item

Full title

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis

Publisher

Cambridge, UK: Cambridge University Press

Journal title

The international journal of neuropsychopharmacology, 2013-07, Vol.16 (6), p.1205-1218

Language

English

Formats

Publication information

Publisher

Cambridge, UK: Cambridge University Press

More information

Scope and Contents

Contents

Because early treatment choice is critical in first-episode schizophrenia-spectrum disorders (FES), this meta-analysis compared efficacy and tolerability of individual second-generation antipsychotics (SGAs) with first-generation antipsychotics (FGAs) in FES. We conducted systematic literature search (until 12 December 2010) and meta-analysis of ac...

Alternative Titles

Full title

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3594563

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3594563

Other Identifiers

ISSN

1461-1457

E-ISSN

1469-5111

DOI

10.1017/S1461145712001277

How to access this item